• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-met 和 HGF/c-met 通路的异常表达为 B 慢性淋巴细胞白血病提供了生存优势。

Aberrant expression of c-met and HGF/c-met pathway provides survival advantage in B-chronic lymphocytic leukemia.

机构信息

Department of Hematology-Immunology, School of Medicine, Marmara University, Istanbul, Turkey.

出版信息

Cytometry B Clin Cytom. 2011 Jan;80(1):1-7. doi: 10.1002/cyto.b.20553. Epub 2010 Aug 31.

DOI:10.1002/cyto.b.20553
PMID:20809501
Abstract

BACKGROUND

B-chronic lymphocytic leukemia (B-CLL) is characterized by accumulation of CD5(+) B lymphocytes. Decreased VLA-4 (Cd49d/CD29) and CD11a expression and defective adhesion in B-CLL have been previously shown, although there was no substantial data about its importance in immunobiology of B-CLL. The hepatocyte growth factor (HGF) receptor, c-met, plays a role in adhesion by acting on VLA-4. c-met and VLA-4 share crucial signaling molecules in cell survival. In this study, relationship between expressions of c-met and CD49d, CD11a, and additional common signaling molecules in B-CLL was investigated.

METHODS

White blood cells from 24 patients with CLL were studied by flow cytometry and/or western blotting prior to and after culturing with recombinant HGF. HGF level from sera was measured with a bead-based flow cytometric assay.

RESULTS

c-metα and c-metβ were expressed on B-CLL cells, while no expression was observed on normal donor CD19+ cells. This increase was inversely correlated with decreased expression of adhesion molecules. Serum level of HGF in B-CLL was found to be increased. In vitro experiments showed that HGF supported survival in B-CLL cells supporting the possible function of HGF/c-met pathway in B-CLL. Furthermore, expressions of critical signaling molecules shared by both VLA-4 and HGF/c-met systems including Bcl-XL, Akt, PI3K, and phospho-bad(136) following HGF stimulations of B-CLL cells have been found to be increased.

CONCLUSION

Increased expression of c-met and HGF may bypass the importance of expression of critical adhesion molecules and support survival of B-CLL cells. c-met, being one of the surface tyrosine kinases, may serve as a target for future therapies in B-CLL meriting more attention.

摘要

背景

B 慢性淋巴细胞白血病(B-CLL)的特征是 CD5(+)B 淋巴细胞的积累。先前已经表明,B-CLL 中存在 VLA-4(Cd49d/CD29)和 CD11a 表达降低以及黏附功能缺陷,尽管在其在 B-CLL 免疫生物学中的重要性方面没有实质性数据。肝细胞生长因子(HGF)受体 c-met 通过作用于 VLA-4 发挥黏附作用。c-met 和 VLA-4 在细胞存活中共享关键信号分子。在这项研究中,研究了 B-CLL 中 c-met 与 CD49d、CD11a 和其他共同信号分子表达之间的关系。

方法

在使用重组 HGF 培养之前和之后,通过流式细胞术和/或 Western blot 研究了 24 例 CLL 患者的白细胞。使用基于珠的流式细胞术测定法测量血清中 HGF 的水平。

结果

c-metα 和 c-metβ 在 B-CLL 细胞上表达,而在正常供体 CD19+细胞上未观察到表达。这种增加与黏附分子表达降低呈负相关。发现 B-CLL 中的 HGF 血清水平增加。体外实验表明,HGF 支持 B-CLL 细胞的存活,支持 HGF/c-met 途径在 B-CLL 中的可能功能。此外,还发现了 VLA-4 和 HGF/c-met 系统共有的关键信号分子的表达增加,包括 Bcl-XL、Akt、PI3K 和磷酸化 bad(136),这是在 B-CLL 细胞受到 HGF 刺激后。

结论

c-met 和 HGF 的表达增加可能绕过关键黏附分子表达的重要性,并支持 B-CLL 细胞的存活。c-met 作为表面酪氨酸激酶之一,可能成为未来 B-CLL 治疗的靶点,值得更多关注。

相似文献

1
Aberrant expression of c-met and HGF/c-met pathway provides survival advantage in B-chronic lymphocytic leukemia.c-met 和 HGF/c-met 通路的异常表达为 B 慢性淋巴细胞白血病提供了生存优势。
Cytometry B Clin Cytom. 2011 Jan;80(1):1-7. doi: 10.1002/cyto.b.20553. Epub 2010 Aug 31.
2
Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.肝细胞生长因子诱导慢性淋巴细胞白血病的生存及免疫抑制作用
Curr Mol Med. 2017;17(1):24-33. doi: 10.2174/1566524017666170220095838.
3
Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.B细胞慢性淋巴细胞白血病中CD49d抗原的可变表达与疾病分期相关。
Leukemia. 1996 Aug;10(8):1331-9.
4
Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.分析稳态趋化因子 CCL19 和 CCL21 诱导 B 细胞慢性淋巴细胞白血病中迁移和生存途径。
Exp Hematol. 2010 Sep;38(9):756-64, 764.e1-4. doi: 10.1016/j.exphem.2010.05.003. Epub 2010 May 19.
5
Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor.人骨髓瘤细胞在肝细胞生长因子的作用下黏附于纤连蛋白。
Haematologica. 2005 Apr;90(4):479-88.
6
The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.散射因子/肝细胞生长因子:c-met通路在人类胚胎中枢神经系统肿瘤恶性肿瘤中的作用
Cancer Res. 2005 Oct 15;65(20):9355-62. doi: 10.1158/0008-5472.CAN-05-1946.
7
Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.PI3K/Akt信号通路在肝细胞生长因子诱导的葡萄膜黑色素瘤细胞迁移中的作用
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):497-504. doi: 10.1167/iovs.07-0975.
8
Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.小细胞肺癌中c-Met/肝细胞生长因子信号通路的调控
Clin Cancer Res. 2002 Feb;8(2):620-7.
9
Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.与血管内皮细胞相互作用通过 NF-κB 激活和从头基因转录增强原发性慢性淋巴细胞白血病细胞的存活。
Cancer Res. 2010 Oct 1;70(19):7523-33. doi: 10.1158/0008-5472.CAN-10-1634. Epub 2010 Aug 24.
10
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.CD49d/CD29 复合物在物理和功能上与 B 细胞慢性淋巴细胞白血病细胞中的 CD38 相关联。
Leukemia. 2012 Jun;26(6):1301-12. doi: 10.1038/leu.2011.369. Epub 2012 Jan 6.

引用本文的文献

1
JCMM Annual Review on Advances in Biotechnology for the Treatment of Haematological Malignancies: A Review of the Latest In-Patient Developments 2024-2025.《JCMM关于血液恶性肿瘤治疗生物技术进展的年度回顾:2024 - 2025年最新住院治疗进展回顾》
J Cell Mol Med. 2025 Jul;29(13):e70700. doi: 10.1111/jcmm.70700.
2
HGF/c-MET axis contributes to CLL cell survival by regulating multiple mechanisms making it a potential therapeutic target for CLL treatment.HGF/c-MET轴通过调节多种机制促进慢性淋巴细胞白血病(CLL)细胞存活,使其成为CLL治疗的一个潜在治疗靶点。
Front Pharmacol. 2025 May 30;16:1612916. doi: 10.3389/fphar.2025.1612916. eCollection 2025.
3
Hepatocyte Growth Factor: A Microenvironmental Resource for Leukemic Cell Growth.
肝细胞生长因子:白血病细胞生长的微环境资源。
Int J Mol Sci. 2019 Jan 12;20(2):292. doi: 10.3390/ijms20020292.
4
Up-regulation of SPINT2/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion.去甲基化药物阿扎胞苷上调骨髓间充质基质细胞中 SPINT2/HAI-2 的表达,影响白血病干细胞的存活和黏附。
J Cell Mol Med. 2019 Feb;23(2):1562-1571. doi: 10.1111/jcmm.14066. Epub 2018 Nov 28.
5
Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.基于 T 细胞依赖性鉴定小鼠中不同的未突变慢性淋巴细胞白血病亚群。
Front Immunol. 2018 Sep 13;9:1996. doi: 10.3389/fimmu.2018.01996. eCollection 2018.
6
CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia.CD49d与慢性淋巴细胞白血病患者的结外表现及随后淋巴结病的发展相关。
Br J Haematol. 2017 Jul;178(1):99-105. doi: 10.1111/bjh.14647. Epub 2017 Apr 7.
7
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.慢性淋巴细胞白血病细胞释放的外泌体可诱导基质细胞转变为癌症相关成纤维细胞。
Blood. 2015 Aug 27;126(9):1106-17. doi: 10.1182/blood-2014-12-618025. Epub 2015 Jun 22.
8
Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies.受体酪氨酸激酶的小分子抑制剂:靶向癌症治疗的有前景工具。
Int J Mol Sci. 2014 Aug 8;15(8):13768-801. doi: 10.3390/ijms150813768.
9
The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.酪氨酸激酶受体ROR1在慢性淋巴细胞白血病(CLL)细胞中持续磷酸化。
PLoS One. 2013 Oct 24;8(10):e78339. doi: 10.1371/journal.pone.0078339. eCollection 2013.
10
Critical signal transduction pathways in CLL.慢性淋巴细胞白血病的关键信号转导通路。
Adv Exp Med Biol. 2013;792:215-39. doi: 10.1007/978-1-4614-8051-8_10.